
Please try another search
For the three months ended 31 March 2022, Natus Medical Inc revenues increased 4% to $119.8M. Net income decreased 21% to $1.9M. Revenues reflect Foreign countries segment increase of 6% to $49.8M, United States segment increase of 3% to $70M. Net income was offset by Restructuring increase from $205K to $2.1M (expense), Other expense increase of 46% to $236K (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 119.79 | 128.66 | 113.88 | 115.98 |
Gross Profit | 65.41 | 73.04 | 67.65 | 66.4 |
Operating Income | 4.18 | 4.7 | 8.54 | 6.01 |
Net Income | 1.9 | 1.74 | 5.57 | 3.46 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 568.08 | 564.29 | 561.25 | 556.22 |
Total Liabilities | 137.19 | 139.54 | 138.73 | 138.39 |
Total Equity | 430.89 | 424.75 | 422.52 | 417.83 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 8.9 | 63.99 | 51.21 | 44.1 |
Cash From Investing Activities | -1.63 | -1.95 | -1.27 | -2.97 |
Cash From Financing Activities | 2.52 | -60.66 | -57.97 | -57.85 |
Net Change in Cash | 8.69 | -6.49 | -13.3 | -19.59 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review